Biologics/Biosimilars Webinar Series: Post-Market Legal and Regulatory Issues

Apr
7
2016

Date: April 7, 2016

Time: 11:00AM - 12:00PM

Location: Webinar

Topics

  • Post-Market Legal and Regulatory Issues
     

Event Details

In the face of rising drug costs, patients, payors, and Congress have increasingly focused on the potential cost savings of biosimilars. But given that the first biosimilar hit the market less than a year ago, there are many unanswered questions surrounding the promise of biosimilars. In this fifth installment of our biologics/biosimilars series, we'll focus on the path forward for biosimilars within the pharmaceutical industry.

Professionals

  • Theresa C. Carnegie

    • Related Industries

  • Health Care
  • Life Sciences

    • Speakers

    Professional Cropped Carnegie Theresa Mintz

    Theresa C. Carnegie

    Panelist

    Theresa advises clients on all aspects of the pharmaceutical supply chain, including counseling industry stakeholders on a range of business, legal, transactional, and compliance matters. She provides clients with strategic counseling and creative business modeling that considers legal restrictions and regulatory risk in light of innovation and business goals.

    Panelist